Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender